%0 Journal Article
%T The manganese transporter SLC39A8 links alkaline ceramidase 1 to inflammatory bowel disease.
%A Choi EK
%A Rajendiran TM
%A Soni T
%A Park JH
%A Aring L
%A Muraleedharan CK
%A Garcia-Hernandez V
%A Kamada N
%A Samuelson LC
%A Nusrat A
%A Iwase S
%A Seo YA
%J Nat Commun
%V 15
%N 1
%D 2024 Jun 5
%M 38839750
%F 17.694
%R 10.1038/s41467-024-49049-8
%X The metal ion transporter SLC39A8 is associated with physiological traits and diseases, including blood manganese (Mn) levels and inflammatory bowel diseases (IBD). The mechanisms by which SLC39A8 controls Mn homeostasis and epithelial integrity remain elusive. Here, we generate Slc39a8 intestinal epithelial cell-specific-knockout (Slc39a8-IEC KO) mice, which display markedly decreased Mn levels in blood and most organs. Radiotracer studies reveal impaired intestinal absorption of dietary Mn in Slc39a8-IEC KO mice. SLC39A8 is localized to the apical membrane and mediates 54Mn uptake in intestinal organoid monolayer cultures. Unbiased transcriptomic analysis identifies alkaline ceramidase 1 (ACER1), a key enzyme in sphingolipid metabolism, as a potential therapeutic target for SLC39A8-associated IBDs. Importantly, treatment with an ACER1 inhibitor attenuates colitis in Slc39a8-IEC KO mice by remedying barrier dysfunction. Our results highlight the essential roles of SLC39A8 in intestinal Mn absorption and epithelial integrity and offer a therapeutic target for IBD associated with impaired Mn homeostasis.